Ftse Mib
34.792,56
0,87%
DAX
18.667,70
1,00%
S&P 500
5.277,51
0,00%
NASDAQ
16.735,02
0,00%
Bitcoin
69.648,00
2,80%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Australia ASX Australian Clinical Labs Limited (ACL) Australian Clinical Labs Limited (ACL) Notizie

ACL

Australian Clinical Labs (ACL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:ASX:ACL
DataOraFonteTitoloSimboloCompagnia
29/05/201507:06The Motley FoolAlchemia Limited slammed 53%: Is the stock a buy?ASX:ACLAustralian Clinical Labs Limited
13/07/201111:17Dow Jones NewsUPDATE: Dr Reddy's Gets US OK For Generic Anticlotting InjectionASX:ACLAustralian Clinical Labs Limited
13/07/201107:27Dow Jones NewsDr Reddy's Gets US OK To Sell Generic Injection To Prevent Blood ClotsASX:ACLAustralian Clinical Labs Limited
28/10/200900:08Dow Jones NewsCORRECT: Alcon 3Q Profit Down 18%, Raises 2009 Earnings ViewNYSE:ACLAlcon Inc.
27/10/200923:42Dow Jones NewsAlcon 3Q Profit Down 18%, Raises 2009 Earnings View 2nd TimeNYSE:ACLAlcon Inc.
12/08/200910:05Dow Jones NewsNestle Sees No Acquisition Opportunities, Alcon Options EyedNYSE:ACLAlcon Inc.
29/06/200917:20Dow Jones NewsNestle: No Need To Renegotiate Alcon Terms With NovartisNYSE:ACLAlcon Inc.
26/06/200921:21Dow Jones NewsUPDATE: River Plate Eye Product Gets Thumbs Down From PanelNYSE:ACLAlcon Inc.
26/06/200920:42Dow Jones NewsRiver Plate Eye Product Gets Thumbs Down From FDA PanelNYSE:ACLAlcon Inc.
24/06/200916:53Dow Jones NewsUPDATE: FDA: ISTA Eye Drop Effective; Concern On RejenaNYSE:ACLAlcon Inc.
22/05/200922:34Dow Jones NewsFDA: Doctors Must Tell People About Lasik Eye Surgery RisksNYSE:ACLAlcon Inc.
07/05/200918:05Dow Jones NewsNovartis CEO: Co Hopes To Buy 52% Alcon Stake From NestleNYSE:ACLAlcon Inc.
23/04/200915:35Dow Jones NewsNovartis: No Changes To Nestle Agreement On Alcon PlannedNYSE:ACLAlcon Inc.
22/04/200914:20Dow Jones NewsGlaxoSmithKline CEO: Still Not Interested In Large M&ANYSE:ACLAlcon Inc.
20/02/200911:30Dow Jones NewsCORRECT(2/19):Nestle 2nd Half Net Jumps;Indicates Will Keep L'OrealNYSE:ACLAlcon Inc.
20/02/200911:15Dow Jones NewsCORRECT(2/19):Nestle Hints Will Keep L'Oreal;No Alcon Terms ChangeNYSE:ACLAlcon Inc.
19/02/200912:38Dow Jones NewsNestle Open For Purchases, No Major Acquisition In SightNYSE:ACLAlcon Inc.
19/02/200912:21Dow Jones NewsUPDATE: Nestle Hints Will Keep L'Oreal; No Alcon Terms ChangeNYSE:ACLAlcon Inc.
19/02/200911:58Dow Jones News2nd UPDATE: Nestle 2nd Half Net Jumps; Indicates Will Keep L'OrealNYSE:ACLAlcon Inc.
19/02/200910:36Dow Jones NewsUPDATE: Nestle 2nd Half Net More Than Doubles; Tones Down OutlookNYSE:ACLAlcon Inc.
19/02/200910:21Dow Jones NewsNestle Not Pressed On L'Oreal, No Plan To Change Alcon TermsNYSE:ACLAlcon Inc.
19/02/200908:51Dow Jones NewsNestle 08 Net Profit Jumps 69% On Windfall; Oulook CautiousNYSE:ACLAlcon Inc.
19/02/200908:30Dow Jones NewsNestle '08 Net Profit Up 69%, Sees Growth Slowdown In '09NYSE:ACLAlcon Inc.
19/02/200907:59Dow Jones NewsNestle '08 Net Profit Up 69%, Sees Growth -2-NYSE:ACLAlcon Inc.
12/02/200918:48Dow Jones NewsAlcon Trims Staff Amid Generic Competition For Eye DrugNYSE:ACLAlcon Inc.
12/02/200904:09Dow Jones NewsAlcon 4Q EPS Up 12%, Sees FY09 Non-GAAP EPS Shy Of Street ViewNYSE:ACLAlcon Inc.
12/01/200922:06Dow Jones NewsAbbott Standing Pat Now, But Vision Deal Could Yield MoreNYSE:ACLAlcon Inc.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:ASX:ACL

La tua Cronologia

LSE
92XN
07sep2038c
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network